Double blind randomized placebo controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.
Dasarathy S, Dasarathy J, Khiyami A, et al. J Clin Gastroenterol. 2015.
PUFA showed no benefit over placebo in NASH patients with diabetes in terms of liver enzymes, body weight or body composition, and did not show a positive impact on insulin response.